Joanna-Grace M Manzano, MD, MPH, FACP
Department of Hospital Medicine, Division of Internal Medicine
Present Title & Affiliation
Primary Appointment
Associate Professor, Department of Hospital Medicine, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Associate Professor, Department of Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Postgraduate Training
| 2019-2019 | Clinical Safety and Effectiveness Program, Office of Performance Improvement, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2015-2015 | AAMC Minority Career Development Program, Association of American Medical Colleges, Atlanta, Georgia |
| 2013-2018 | Master Degree in Public Health, Major in Epidemiology, The University of Texas School of Public Health, Houston, Texas |
| 2012-2013 | Certificate in Public Health, The University of Texas School of Public Health, Houston, Texas |
| 2012-2013 | Clinical Research Fellow, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2011-2012 | Chief Residency, New York Medical College – Sound Shore Medical Center of Westchester, New Rochelle, New York |
| 2009-2011 | Internal Medicine Residency, New York Medical College – Sound Shore Medical Center of Westchester, New Rochelle, New York |
| 2008-2009 | Internal Medicine Clinical Internship, New York Medical College-Sound Shore Medical Center of Westchester, New Rochelle, New York |
| 2003-2004 | Clinical Internship, University of Santo Tomas Hospital, Manila |
Experience & Service
Other Appointments/Responsibilities
Program Lead, COVID Transition of Care, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - Present
Provider Lead, Readmissions Action Team, Hospital Flow Team, Discharge and Readmissions Patient Flow Team, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - Present
Provider Lead, Discharge Planning Action Team, Hospital Flow Team, Discharge and Readmissions Patient Flow Team, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - Present
Provider Lead, Expected Discharge Action Team, Hospital Flow Team, Discharge and Readmissions Patient Flow Team, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - Present
Subcommittee Lead, Discharge Planning and Research, Utilization Review Committee, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - Present
Honors & Awards
| 2017 | Election to Fellowship in the American College of Physicians by the Board of Regents of the American College of Physicians |
| 2016 | Finalist. Excellence in Research Awards, Faculty Division, Fourth State of the Science Cancer Survivorship Research Symposium |
| 2016 | 2016 James S. and Suzanne Cyrus Scholar Awards Finalist in Outstanding Clinical Research, The University of Texas MD Anderson Cancer Center |
| 2014 | 2014 James S. and Suzanne Cyrus Scholar Awards Finalist in Outstanding Clinical Research, University of Texas MD Anderson Cancer Center |
| 2014 - 2025 | Comparative Effectiveness Research on Cancer in Texas (CERCIT) Scholar under the Training Core |
| 2014 | First Place, 2014 Division of Internal Medicine Quality Improvement Projects, University of Texas MD Anderson Cancer Center |
| 2013 | Third Place, 2013 Division of Internal Medicine Poster Competition, University of Texas MD Anderson Cancer Center |
| 2013 | Postgraduate award in Population/Patient-Oriented Research, University of Texas MD Anderson Cancer Center |
| 2013 - 2025 | Clinician-Investigator Training Program Scholar, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center |
| 2012 | Outstanding Service as Chief Medical Resident, Sound Shore Medical Poster Competition, Department of Medicine |
| 2003 | Benemeritus, University of Santo Tomas, Faculty of Medicine and Surgery |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Simbaqueba Clavijo, CA, Odaro, OE, Gandhi, A, Koom-Dadzie, K, Musaelyan, A, Dickson, KB, Chua, R, Bhise, VR, Amoateng, MD, Tomy, S, Leal Alviarez, DJ, Phyu, EM, Bogdanich, I, Andersen, C, Sheshadri, A, Palaskas, NL, Halm, J, Manzano, JM. Immunotherapy-Related Adverse Events and Clinical Outcomes in Adult Solid-Tumor Patients Admitted to an Onco-Hospitalist Medicine Service. Cancers 17(3), 2025. e-Pub 2025. PMID: 39941771.
- Brito-Dellan, N, Franco Vega, M, Ruiz, JI, Lu, M, Sahar, HN, Rajapakse, P, Lin, HY, Peterson, CB, Leal Alviarez, DJ, Altay, H, Tomy, S, Manzano, JM. Optimizing inpatient care for lung cancer patients with immune checkpoint inhibitor-related pneumonitis using a clinical care pathway algorithm. Supportive Care in Cancer 32(10), 2024. e-Pub 2024. PMID: 39283351.
- Manzano, JM, Sahar, H, Aldrich, J, Lu, M, Shoukier, M, Peterson, CB, Dickson, KB, Koom-Dadzie, K, Kheder, E, Franco Vega, M, Mohammed, AD, Muthu, M, Simbaqueba Clavijo, CA, Senechalle, MS, Brito-Dellan, N. Treatment patterns and outcomes of high-grade immune checkpoint inhibitor-related pneumonitis in an oncology hospitalist service. Supportive Care in Cancer 32(3), 2024. e-Pub 2024. PMID: 38366007.
- Leung, CK, Walton, NC, Kheder, E, Zalpour, A, Wang, J, Zavgorodnyaya, D, Kondody, S, Zhao, C, Lin, Y, Bruera, E, Manzano, JM. Understanding Potentially Preventable 7-day Readmission Rates in Hospital Medicine Patients at a Comprehensive Cancer Center. American Journal of Medical Quality 39(1):14-20, 2024. e-Pub 2024. PMID: 38127668.
- Kuang, AG, Sperling, G, Liang, TZ, Lu, Y, Tan, D, Bollin, KB, Johnson, DB, Manzano, JM, Shatila, M, Thomas, AS, Thompson, JA, Zhang, HC, Wang, Y. Sclerosing mesenteritis following immune checkpoint inhibitor therapy. Journal of cancer research and clinical oncology 149(11):9221-9227, 2023. e-Pub 2023. PMID: 37195298.
- Noh, S, Bertini, CD, Mira-Avendano, I, Kaous, M, Patel, B, Faiz, S, Shannon, VR, Balachandran, D, Bashoura, L, Adachi, R, Evans, S, Dickey, BF, Wu, CC, Shroff, G, Manzano, JM, Granwehr, BP, Holloway, S, Dickson, KB, Mohammed, AD, Muthu, M, Song, H, Aroe, A, Aloia, TA, Lee Andrews, II, Badami, KK, Beird, H, Brock, K, Cata, JP, Dabaja, BS, Draetta, G, French, KE, Godoy, M, Hutcheson, KA, Jaffray, D, John, TM, Lee, JJ, Litton, J, McEnery, KW, Musunuru, TN, Nates, JL, Palaskas, NL, Ravi, V, Scheet, PA, Shete, S, Subbiah, IM, Tawbi, H, Woodman, SE, Chung, C, Khawaja, F, Sheshadri, A. Interstitial lung abnormalities after hospitalization for COVID-19 in patients with cancer. Cancer medicine 12(17):17753-17765, 2023. e-Pub 2023. PMID: 37592894.
- Manzano, JM, Muthu, M, Kheder, E, Mohammed, AD, Halm, J, Dickson, KB, Ali, N, Leung, CK, Koom-Dadzie, K, Rubio, D, Odaro, OE, Sibille, MM, Etchegaray, M, Wilson, K, Lin, Y, George, MC. Hospitalization characteristics and outcomes of patients with cancer and COVID-19 at a comprehensive cancer center. Supportive Care in Cancer 30(9):7783-7788, 2022. e-Pub 2022. PMID: 35705751.
- Jones, SL, Cheon, O, Manzano, JM, Park, AK, Lin, Y, Halm, J, Baek, J, Graviss, EA, Nguyen, DT, Kash, BA, Phillips, RA. Comparison of LACE and HOSPITAL Readmission Risk Scores for CMS Target and Nontarget Conditions. American Journal of Medical Quality 37(4):299-306, 2022. e-Pub 2022. PMID: 34935684.
- Lipe, D, Bourenane, S, Wattana, M, Gaeta, MS, Chaftari, P, Cruz Carreras, MT, Manzano, JM, Reyes-Gibby, CC. A modified emergency severity index level is associated with outcomes in cancer patients with COVID-19. American Journal of Emergency Medicine 54:111-116, 2022. e-Pub 2022. PMID: 35152119.
- Manzano, JM, Lin, Y, Zhao, H, Halm, J, Suarez-Almazor, M. Derivation and Validation of the Cancer READMIT Score. JCO Oncology Practice 18(2):E117-E128, 2022. e-Pub 2022. PMID: 34357793.
- Tennison, JM, Rianon, N, Manzano, JM, Munsell, M, George, MC, Bruera, E. Thirty-day hospital readmission rate, reasons, and risk factors after acute inpatient cancer rehabilitation. Cancer medicine 10(18):6199-6206, 2021. e-Pub 2021. PMID: 34313031.
- Manzano JG, Lin H, Zhao H, Halm J, Suarez-Almazor ME. Derivation and Validation of the Cancer READMIT Score: A Readmission Risk Scoring System for Patients with Solid Tumor Malignancies. J Oncol Pract, 2021. e-Pub 2021.
- Tennison JM, Rianon NJ, Manzano JG, Munsell MF, George MC, Bruera E. Thirty-day hospital readmission rate, reasons, and risk factors after acute inpatient cancer rehabilitation. Cancer Med:1-8, 2021. e-Pub 2021.
- Narayanan S, Reddy A, Lopez G, Liu W, Wu J, Liu D, Manzano J, Williams JL, Mallaiah S, George M, Amaram J, Subramaniam B, Cohen L, Bruera E. Randomized Feasibility Study of Meditative Practices in Hospitalized Cancer Patients. Integr Cancer Ther 19:1534735420909903, 2020. e-Pub 2020. PMID: 32153208.
- Manasanch E, Mulanovich V, JG <, Gaeta MS, Becnel M, Kaufman GP, Lee HC, Amini B, Thomas SK, Iyer SP, Weber DM, Berkova Z, Flowers CR, Orlowski RZ, Patel KK. (2020) SARS-CoV-2 in Multiple Myeloma: Initial Observation and Management. Leukemia & Lymphoma, 2020. e-Pub 2020.
- John TM, Malek AE, Shpall EJ, Mulanovich VE, Adachi JA, Raad II, Aitken SL, Hamilton AR, Jain N, Klein K, Martinez F, Rezvani K, Jacob CN, Cherian SV, JG <, Wegner R, Muthu M. Migratory Pulmonary Infiltrates in a Patient with COVID-19 Infection and the Role of Corticosteroids. Mayo Clinic Proceedings (2020), 2020. e-Pub 2020.
- John TM, Malek AE, Shpall EJ, Mulanovich VE, Adachi JA, Raad II, Aitken SL, Hamilton AR, Jain N, Klein K, Martinez F, Rezvani K, Jacob CN, Cherian SV, Manzano JGM, Wegner R, Migratory MM. Pulmonary Infiltrates in a Patient with COVID-19 Infection and the Role of Corticosteroids,. Mayo Clinic Proceedings, 2020. e-Pub 2020.
- Manzano J, Park A, Lin H, et al. Demonstrating value: association of cost and quality outcomes with implementation of a value-driven oncology-hospitalist inpatient collaboration for patients with lung cancer. BMJ Open Quality 8:e000381. doi: 10.1136/bmjoq-2018-000381, 2019. e-Pub 2019.
- Manzano JM, Yang M, Zhao H, Elting LS, George MC, Luo R, Suarez-Almazor ME. Readmission Patterns After GI Cancer Hospitalizations: The Medical Versus Surgical Patient. J Oncol Pract 14(3):e137-e148, 2018. e-Pub 2018. PMID: 29443648.
- Manzano JG, Gadiraju S, Hiremath A, Lin HY, Farroni J, Halm J. Unplanned 30-Day Readmissions in a General Internal Medicine Hospitalist Service at a Comprehensive Cancer Center. J Oncol Pract 11(5):410-5, 2015. e-Pub 2015. PMID: 26152375.
- Manzano JG, Luo R, Elting LS, George M, Suarez-Almazor ME. Patterns and predictors of unplanned hospitalization in a population-based cohort of elderly patients with GI cancer. J Clin Oncol 32(31):3527-33, 2014. e-Pub 2014. PMID: 25287830.
Invited Articles
- Weaver AC, Manzano JG. Quality and Safety in Hospitalized Patients with Cancer. Hospital Medicine Clinics 5(3), 2016. e-Pub 2016.
Abstracts
- Manzano JG, Sharma, SV, Suarez-Almazor, ME, Lopez-Olivo, A. Association of Diabetes Treatment with Breast Cancer Outcomes: A Systematic Review and Meta-Analysis. 2021 Annual Meeting of the Multinational Association of Supportive Care in Cancer, 2021. e-Pub 2021.
- Manzano JG, Halm J, Muthu M. Hospitalization Characteristics and Outcomes of Patients with Cancer and COVID-19. oral proferred paper at the 2021 Annual Meeting of the Multinational Association of Supportive Care in Cancer, 2021. e-Pub 2021.
- Reddy DR, Wegner R, Crommett J, Muthu M, Kheder E, Manzano JG, Leung C, Rathi N, Gutierrez C, Manjappachar N, Cuenca J, Price K, Nates J. First-Surge COVID-19 Experience at a Comprehensive Cancer Center. Critical Care Medicine 49(1):59, 2021. e-Pub 2021.
- Sahar H, Aldrich J, Peterson C, Brito-Dellan N, Lu M, Shoukier M, Dickson K, Koom-Dadzie K, Kheder E, Franco-Vega M, Mohammed A, Muthu M, Simbaqueba C, Sibille M, Manzano JG. Immune checkpoint inhibitor (ICI)-related pneumonitis among patients with lung cancer admitted to an Oncology Hospitalist Service: Treatment patterns and hospitalization outcomes. Journal of Clinical Oncology(39,DOI: 10.1200/JCO.2021.39.15_suppl.e21054), 2021. e-Pub 2021.
- Manzano JG, Jones S, Kash B, Halm, J, Park A, Lin Y, Phillps R. Leveraging data to understand readmissions in the Texas Medical Center. Accepted for presentation at the 2019 Healthier Texas Summit, Austin, Texas, 2019. e-Pub 2019.
- Kash B, Baek J, Cheon O, Manzano JG, Jones S, Paranilam J, Phillps R. How Leading Hospitals Operationalize Evidence-based Readmission Reduction Strategies. Presented at the American Public Health Association 2018 Annual Meeting, San Diego, California, 2018. e-Pub 2018.
- Amaram-Davila J, Joby R, Neduyavalil B, Lujan S, Ait-aiss M, George M, J||B M, Halm J. Piloting discharges before 11am for hospitalized patients at a comprehensive cancer hospital. Presented at the International Forum on Quality and Safety in Health Care, Melbourne, Australia, 2018. e-Pub 2018.
- J M, Lin, H, Zhao H, Halm, J, Suarez-Almazor, M. Derivation and validation of a Cancer READmIT Score for use among hospitalized patients with solid tumors. Presented at the 2018 Internal Medicine Research Retreat, The University of Texas MD Anderson Cancer Center, Houston, TX, 2018. e-Pub 2018.
- Joby R, Amaram-Davila J, Neduyavalil B, Lujan S, Ait-aiss M, George M, J M, Halm J. Discharges on Genteral Internal Medicine Hospitalist Service – G22. Presented at and won 1st Place for Quality Initiatives. 2018 Division of Internal Medicine Research Retreat, The University of Texas MD Anderson Cancer Center, Houston, TX, 2018. e-Pub 2018.
- Manzano J, Lin, H, Zhao H, Halm, J, Suarez-Almazor, M. Derivation and validation of a Cancer READmIT Score for use among hospitalized patients with solid tumors, 2018. e-Pub 2018.
- Herrera R, Manzano J. Piloting a Transition of Care Clinic on the General Internal Medicine Hospitalist Service. Presented at the 2018 Internal Medicine Research Retreat, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017. e-Pub 2017.
- J M, Lin, H, Park, A, Liu, S, Halm, J. Evaluating the Impact of and Oncology-Hospitalist Model of Inpatient Care on Unplanned 30-day Readmissions among Patients with Lung Cancer. Journal of the National Comprehensive Cancer Network (JNCCN) Vol 15, No 5.5, May 2017. Presented at 2017 NCCN 22nd Annual Con, 2017. e-Pub 2017.
- J M, Barbo, A, Lin, H, Zhao H, Halm, J, Suarez-Almazor, M. Readmission among patients with cancer who were discharged with hospice care. Journal of Clinical Oncology 35 (suppl 8S, abstract 46), 2017. e-Pub 2017.
- Kim, M, Duan, Z, Zhao, H, Holmes, H, Manzano, J J, Giordano, SH, Suarez-Almazor, M. Anti-Dementia and Anti-Hyperlipidemic Medication Use at End of Life in Elderly Lung Cancer Patients:Analysis of SEER-Medicare Dat. Journal of Clinical Oncology 35 (suppl; abstr 10027), 2017. e-Pub 2017.
- Manzano J, Yang M, Zhao H, Elting L, Suarez-Almazor M. Survival Outcomes of Patients with Gastrointestinal Cancer Who Experienced Unplanned Readmissions. 2016 Society of Hospital Medicine Annual Meeting, San Diego, California, 2016. e-Pub 2016.
- Dahbour, I, Abelrahim, M, Page, V, Zhou, S, Shen, C, Yennu, S, Zhao, B, Manzano, J J, George, M, Nates, J, Moss, A, Abudayyeh, A. Survival Benefits among Patients with End-Stage Renal Disease Receiving Dialysis versus No Dialysis. Journal of Clinical Oncology 34 (suppl 26S, abstract 55), 2016. e-Pub 2016.
- Dahbour, I, Abelrahim, M, Page, V, Zhou, S, Shen, C, Yennu, S, Zhao, B, Manzano, J, George, M, Nates, J, Moss, A, Abudayyeh, A. Survival Benefits among Patients with End-Stage Renal Disease Receiving Dialysis versus No Dialysis. Journal of Clinical Oncology(26s):34, 2016. e-Pub 2016.
- Manzano J, Halm J, Hiremath A, Gadiraju S, Lin H, Farroni J. Piloting a cancer readmissions reduction program in a comprehensive cancer hospital. International Forum on Quality and Safety in Health Care, 2015. e-Pub 2015.
- Manzano J, Hiremath A, Farroni J, Yang M, Zhao H, Halm J. Identifying patient factors that could impact readmissions in a comprehensive cancer center. Supportive Care Cancer, 2015. e-Pub 2015.
- Manzano J, Hiremath A, Halm J. Cancer Outcomes Augmented through Safe Transitions (CoastTm) – Piloting a Hospitalist Readmissions Reduction Program in a Comprehensive Cancer Center. Journal of Hospital Medicine 10(suppl 2), 2015. e-Pub 2015.
- Halm J, Gadiraju S, Hiremath, A, Farroni J, Manzano J. Cancer Outcomes Augmented Through Safe Transitions (COAST). Presented at the International Forum on Quality and Safety in Health Care, Paris, France,, 2014. e-Pub 2014.
- Manzano J, Luo R, Elting L, George M, Suarez-Almazor M. Unplanned 30-day Readmissions Among Patients with Gastrointestinal Cancer. Supportive Care in Cancer, 2014. e-Pub 2014.
- Gadiraju S, Manzano J. Reducing 30-day Readmission Rates on the General Internal Medicine Hospitalist Service at M.D. Anderson Cancer Center. Journal of Hospital Medicine, 2014. e-Pub 2014.
- Gadiraju S, Hiremath, A, Jonsson K, Halm J, Manzano J. Reducing the Unplanned Readmission rate on the General Internal Medicine Hospitalist Service. Program/Proceedings of The University of Texas System Clinical Safety and Effectiveness Conference, Public Policy and Public Health Effect Health Care Reform, San Antonio, TX, 2013. e-Pub 2013.
- Manzano J, Luo R, Elting L, Suarez-Almazor M. Unplanned Hospitalizations Among Gastrointestinal Cancer Patients in the State of Texas. Journal of Clinical Oncology, 2013. e-Pub 2013.
- Manzano J, Luo R, Elting L, Suarez-Almazor M. Unplanned Hospitalizations Among Gastrointestinal Cancer Patients in the State of Texas. 2nd Conference on Medical Issues in Cancer Patients and Survivors, UT MD Anderson Cancer Center, Houston, TX, 2013. e-Pub 2013.
- Manzano J, Luo R, Elting L, Suarez-Almazor M. 30-day Readmission Among Gastrointestinal Cancer Patients in Texas. Journal of Clinical Oncology, 2013. e-Pub 2013.
- Chua R, Manzano J, Schiffmiller M, Poste J, Jesmajian S. Adrenal Carcinoma Presenting as Hypoglycemia: A Case Report. American College of Physicians Internal Medicine 2012, New Orleans, La,:383, 2012. e-Pub 2012.
Selected Presentations & Talks
Local Presentations
- 2020. 30 Days of COVID – MDACC Inpatient Experience. Conference. The University of Texas at MD Anderson Cancer Center. Houston, TX, US.
- 2019. Utilization of the Expected Discharge Date Field to Improve Inpatient Care Coordination (XDisDate). Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2018. Effect of Diabetes Treatment on Breast Cancer Outcomes: A Systemic Review and Meta-Analysis. Conference. The University of Texas School of Public Health. Houston, TX, US.
- 2017. Quality Improvement Presentations - Session Fice. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2017. Demonstrating Value: Implementation of a Value-and-Outcomes-Driven Oncology-Hospitalist Inpatient Coordination. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2015. Common Cases on the Oncology Hospitalist Service. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2015. Cancer Hospitalizations. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2015. Predictors of Readmission in Cancer Patients. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2014. Reducing 30-day Readmissions and Evaluating Risk Factors in Cancer Patients. Conference. The University of Texas MD Anderson Cancer Center,. Houston, TX, US.
National Presentations
- 2017. Evaluating the Impact an Oncology-Hospitalist Model of Inpatient Care on Unplanned 30-day Readmissions among Patients with Lung Cancer. Conference. 2017 NCCN 22nd Annual Conference. Orlando, FL, US.
International Presentations
- 2021. Hospitalization Characteristics and Outcomes of Patients with Cancer and COVID-19. Conference. Multinational Association of Supportive Care in Cancer Annual Meeting, US.
- 2017. Improving Outcomes of Unplanned 30-Day Readmissions for Lung Cancer. Conference. 2017 National Association for Healthcare Quality – NAHQ Next. Cincinnati, US.
- 2017. Readmission among Patients with Cancer who were Discharged with Hospice Care. Conference. ASCO Quality Care Symposium. Orlando, US.
- 2016. 10-year Trends in Unplanned Readmission and Survival Rates among Patients with Gastrointestinal Cancer. Conference. Annual Meeting of the Multinational Association of Supportive Care in Cancer. Adelaide, AU.
- 2014. Unplanned 30-day Readmissions among Elderly Patients with Gastrointestinal Cancer. Conference. International Symposium on Supportive Care in Cancer. Miami, US.
Formal Peers
- 2021. Changing the Game for Patients with EES-SCLC through Multidisciplinary Collaboration – Best Practices to Optimize Immunotherapy-Based Approaches and Improve Patient Outcomes. Invited, US.
- 2018. Operationalizing Hospital Readmissions. Continuing Medical Education Luncheon Series. Invited. Houston, TX, US.
- 2018. Readmission Patterns after GI Cancer Hospitalizations: The Medical vs Surgical Patient. Readmissions in Real time. Invited, US.
- 2018. The Hospital Discharge Management Initiative – How we are reducing risk by discharging early, and tools that primary providers and consultants can use for safe and effective discharge planning. Visiting. Houston, TX, US.
- 2017. Derivation and Validation of a Readmission Risk Scoring System in Cancer Patients. Visiting. Houston, TX, US.
- 2017. “Hospitalization after Hospice – Who. Why…. Visiting. Houston, TX, US.
- 2016. Survival Outcomes of Patients with Gastrointestinal Cancer who Experienced 30-Day Unplanned Readmissions,. Visiting. Houston, TX, US.
- 2015. Common Cases on the Oncology Hospitalist Service. Visiting. Houston, TX, US.
- 2014. Designing a Randomized Double-Blind Controlled Trial. Visiting. Houston, TX, US.
- 2014. Unplanned 30-day Readmissions among Elderly Patients with Gastrointestinal Cancer. Visiting. Miami Beach, FL, US.
- 2014. Unplanned 30-day Readmissions among Elderly Patients with Gastrointestinal Cancer. Visiting. Houston, TX, US.
- 2014. 2014 Evidence-Based Guideline to the Management of High Blood Pressure in Adults (JNC 8): The Minority View. Visiting. Houston, TX, US.
- 2014. Refractory Hypocalcemia. Visiting. Houston, TX, US.
- 2014. Evidence-based Approach to Clinical Medicine. Visiting. Houston, TX, US.
- 2013. 30-day Readmissions among GI Cancer Patients. Visiting. Houston, TX, US.
- 2013. Critical Appraisal of Systematic Reviews and Meta-Analyses. Visiting. Houston, TX, US.
- 2013. Reducing Readmission Rates. Visiting. Houston, TX, US.
- 2013. Unplanned Hospitalizations among Gastrointestinal Cancer Patients in the State of Texas. Visiting. Houston, TX, US.
- 2013. Unplanned Admissions and Readmissions among Elderly Patients with Gastrointestinal Malignancy in the State of Texas: a Population-based Retrospective Cohort Study. Visiting. Houston, TX, US.
- 2012. All Cause Readmission to Acute Care for Cancer. Visiting. Houston, TX, US.
- 2012. Low-dose Aspirin for Preventing Recurrent Venous Thromboembolism: Results of the ASPIRE + WARFASA trials. Visiting. Houston, TX, US.
- 2011. Epidemiology of Pulmonary Embolism and Deep Venous Thrombosis at Sound Shore Medical Center: Identifying Risk Factors and Describing Patterns of Management in a Community-Based Hospital. Visiting. New Rochelle, NY, US.
- 2010. Cervical Cancer. Visiting. New Rochelle, NY, US.
- 2010. Evidence-Based Medicine: Dilemmas in Medical Management and Diagnosis. Visiting. New Rochelle, NY, US.
- 2010. Evidence-Based Medicine: DVT Prophylaxis in Malignancy. Visiting. New Rochelle, NY, US.
- 2010. Evidence-Based Medicine: Pre-diabetes. Visiting. New Rochelle, NY, US.
- 2010. Evidence-Based Medicine: Herpes Zoster & Post-Herpetic Neuralgia. Visiting. New Rochelle, NJ, US.
- 2010. Introduction to Evidence-Based Medicine. Visiting. New Rochelle, NY, US.
- 2009. Cerebral Venous Thrombosis. Visiting. New Rochelle, NY, US.
- 2009. Tracheostomy and Pleural Effusions. Visiting. New Rochelle, NY, US.
- Cancer Readmissions. Visiting. Houston, TX, US.
Grant & Contract Support
| Date: | 2021 - 2023 |
| Title: | Implementation of a Care Pathway for Hospitalized Patients with Suspected Immune Checkpoint Inhibitor |
| Funding Source: | A Quality Improvement Project |
| Role: | Project Leader |
| Date: | 2016 - 2016 |
| Title: | The TEXAS Project: Transitions Explored and Studied: Leveraging Data to Prevent Readmissions in the TMC |
| Funding Source: | Texas Medical Center Health Policy Institute |
| Role: | Co-I |
| Date: | 2015 - 2017 |
| Title: | Derivation and Validation of a Readmission Risk Scoring System in Cancer Patients |
| Funding Source: | University of Texas System Healthcare Safety and Effectiveness Grants Program |
| Role: | PI |
Patient Reviews
CV information above last modified May 07, 2025